2017-03-24,Lifshitz & Miller LLP Announces Investigation Of Argos Therapeutics, Inc., Avid Technology, Inc., HMS Holdings Corp., Invuity, Inc., SITO Mobile, Ltd., Trevena, Inc., USANA Health Sciences, Inc. And VAALCO Energy, Inc.
2017-02-27,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving The Board Of Argos Therapeutics, Inc. -- ARGS
2017-02-22,SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving The Board Of Argos Therapeutics, Inc.
2017-02-22,S&P 500 Trades Lower as Fed Signals Move on Rates 'Fairly Soon'
2017-02-22,Dow Turns Positive in Wishy-Washy Trading Ahead of Fed Minutes
2017-02-22,Argos Therapeutics Tanks on Committee Suggestion to Stop Carcinoma Drug Study
2017-02-22,Stock Futures Waver as Wall Street Awaits Clarity From the Fed
2017-02-22,Argos Plummets 72%, Leads Biotech Movers
2017-02-22,Independent Data Monitoring Committee Recommends Discontinuation Of The ADAPT Phase 3 Clinical Trial Of Rocapuldencel-T In Metastatic Renal Cell Carcinoma For Futility Following Its Planned Interim Data Review
2017-02-13,Argos Therapeutics To Participate In 2017 Genitourinary Cancers Symposium
2017-02-10,Argos Therapeutics Stock Sees Short Interest Make 10.3% Move
2017-02-06,Argos Therapeutics To Participate In BIO CEO And Investor Conference
2017-02-02,Notable Thursday Option Activity: ARGS, CGI, MNKD
2017-01-19,Argos Therapeutics Completes Lease Agreement For Commercial Manufacturing Space On The Centennial Campus Of North Carolina State University
2016-12-14,Argos Therapeutics Enters Into Strategic Research Agreement With Personalis, Inc.
2016-12-13,Argos Therapeutics Appoints Dr. Ralph Snyderman And Irackly Mtibelishvily To The Company's Board Of Directors
2016-12-07,Argos Therapeutics Reports Highlights From Investor Day In New York City
2016-12-01,Argos Therapeutics Opens Registration For Upcoming Investor Day
2016-11-18,Cellthera Presents Preclinical Data At SITC Using Argos' Individualized Immunotherapy
2016-11-14,Argos Therapeutics Participating In Strategies For An HIV Cure 2016 Meeting
2016-11-14,Argos Therapeutics Reports Third Quarter 2016 Financial Results And Recent Operational Highlights
2016-11-11,Argos Therapeutics To Participate In Upcoming Investor Conferences
2016-11-10,Argos Therapeutics To Participate In SITC 2016 Annual Meeting
2016-11-07,Argos Therapeutics To Host Third Quarter 2016 Financial Results Conference Call On Monday, November 14, 2016
2016-11-03,Argos Therapeutics Announces Publication Of A Case Report On Long-term Survival Of Kidney Cancer Patients Treated With AGS-003 Individualized Immunotherapy Featured In The Kidney Cancer Journal
2016-11-02,Argos Therapeutics Participating In 4th International MRNA Health Conference
2016-10-26,Argos Therapeutics Announces CEO Jeff Abbey Elected To NCBIO Board Of Directors
2016-10-19,Argos Therapeutics To Host Investor Day On Wednesday, December 7, 2016
2016-10-14,Argos Therapeutics To Participate In 2016 BIO Investor Forum
2016-10-04,Is This Octoberfest? No, It's Chopfest
2016-10-03,Argos Therapeutics To Participate In 2016 Cell & Gene Meeting On The Mesa
2016-09-27,Short Interest In Argos Therapeutics Jumps 24.8%
2016-09-01,Argos Therapeutics To Participate In 23rd Annual NewsMakers In The Biotech Industry Conference
2016-08-16,Argos Therapeutics is Now Oversold (ARGS)
2016-08-10,Argos Therapeutics Reports Second Quarter 2016 Financial Results And Recent Operational Highlights
2016-08-04,Argos Therapeutics To Host Second Quarter 2016 Financial Results Conference Call On Wednesday, August 10, 2016
2016-07-28,Argos Therapeutics Announces Pricing Of $50 Million Public Offering Of Common Stock And Warrants
2016-07-27,Argos Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants
2016-07-21,These 5 Stocks Under $10 Are Set to Soar Higher
2016-07-14,Argos Therapeutics Announces First Patient Dosed In Stage 2 Of Adult Eradication Trial Of AGS-004 In The Treatment Of HIV
2016-07-13,Short Interest In Argos Therapeutics Jumps 18.2%
2016-07-11,Dr. Richard D. Katz Joins Argos Therapeutics As Chief Financial Officer
2016-06-29,Argos Therapeutics Announces Closing Of $29.8 Million Second Tranche Of March 2016 Financing
2016-06-27,Argos Therapeutics Added To The Russell 2000® Index
2016-06-15,Argos Therapeutics Enters Into Strategic Research Agreement With Adaptive Biotechnologies
2016-06-13,Independent Data Monitoring Committee Recommends Continuation Of ADAPT Phase 3 Clinical Trial Of AGS-003 In Metastatic Renal Cell Carcinoma Following Interim Data Review
2016-06-08,Argos Therapeutics To Participate In Jefferies 2016 Healthcare Conference
2016-05-12,Argos Therapeutics Reports First Quarter 2016 Financial Results And Operational Highlights
2016-05-11,Argos Therapeutics To Participate In World Stem Cells And Regenerative Medicine Congress
2016-05-09,7 Stocks Under $10 Spiking Toward Big Gains
2016-05-05,Argos Therapeutics To Host First Quarter 2016 Financial Results Conference Call On Thursday, May 12, 2016
2016-04-07,Argos Therapeutics To Participate In 15th Annual Needham Healthcare Conference
2016-03-29,CORRECTION -- Argos Therapeutics Reports Fourth Quarter And Full-Year 2015 Financial Results And Operational Highlights
2016-03-29,Argos Therapeutics Reports Fourth Quarter And Full-Year 2015 Financial Results And Operational Highlights
2016-03-23,Argos Therapeutics Announces Initiation Of A Phase 2 Clinical Trial Of AGS-003 For The Treatment Of Non-small Cell Lung Cancer In Combination With Standard-of-Care Chemotherapy
2016-03-22,Argos Therapeutics To Host Fourth Quarter And Full-Year 2015 Financial Results Conference Call On Tuesday, March 29, 2016
2016-03-22,Argos Therapeutics To Participate In 6th Annual "Cancer Immunotherapy: A Long-Awaited Reality" Conference
2016-03-17,Argos Therapeutics To Participate In Alliance For Regenerative Medicine Cell And Gene Therapy Investor Day
2016-03-08,Biotech Rally Is Healing Small-Caps
2016-03-07,Argos Therapeutics Announces Financing Of Up To $60 Million
2016-03-06,We Need to Digest the Feast Before Rallying Again
2016-02-08,8 Stocks Under $10 Set to Soar
2016-01-22,5 Stocks Ready for Breakouts
2016-01-20,Dr. Lee F. Allen Joins Argos Therapeutics As Chief Medical Officer
2015-12-18,4 Biotech Stocks Under $10 Poised for Big Breakouts
2015-12-10,Independent Data Monitoring Committee Recommends Continuation Of ADAPT Phase 3 Clinical Trial Of AGS-003 For Metastatic Renal Cell Carcinoma Following Second Planned Interim Analysis
2015-12-09,Argos Therapeutics To Participate In The ROTH Immuno-Oncology Corporate Access Day
2015-11-16,Argos Therapeutics Reports Third Quarter 2015 Financial Results And Operational Highlights
2015-11-09,Argos Therapeutics To Host Third Quarter 2015 Financial Results Conference Call On Monday, November 16, 2015
2015-11-06,Argos Therapeutics To Participate In 3rd Annual EU Advanced Therapies Investor Day
2015-11-05,Argos Therapeutics To Participate In The 3rd International MRNA Health Conference
2015-10-05,Argos Therapeutics To Host Review Of The Current Clinical Research Landscape In Kidney Cancer Following The 40th Congress Of The European Society For Medical Oncology, With Insights From Dr. Charles Drake Of Johns Hopkins Sidney Kimmel Cancer Center
2015-10-02,Argos Therapeutics To Participate In 2015 Stem Cell Meeting On The Mesa
2015-09-23,Robert F. Carey Appointed To The Board Of Directors Of Argos Therapeutics
2015-09-08,Argos Therapeutics To Participate In FBR Second Annual Healthcare Conference
2015-09-01,Argos Therapeutics To Participate In Stem Cells And Regenerative Medicine Congress 2015
2015-08-24,Argos Therapeutics Awarded Patent For Its Experimental Individualized Immunotherapy For The Treatment Of HIV Infection
2015-08-12,Argos Therapeutics Reports Second Quarter 2015 Financial Results And Operational Highlights
2015-08-10,Argos Therapeutics Announces Pilot Clinical Trial Of AGS-003 As Neoadjuvant Immunotherapy For Localized Renal Cell Carcinoma
2015-08-05,Argos Therapeutics To Hold Second Quarter 2015 Financial Results Conference Call On Wednesday, August 12, 2015
2015-07-21,Argos Therapeutics Announces Formation Of Scientific Advisory Board
2015-07-17,Argos Therapeutics To Present At 8th IAS Conference On HIV Pathogenesis, Treatment And Prevention
2015-07-15,Argos Therapeutics Announces Completion Of Patient Enrollment In Pivotal Phase 3 ADAPT Clinical Trial Of AGS-003
2015-06-24,Argos Therapeutics Becomes Oversold (ARGS)
2015-06-16,Argos Therapeutics To Present At The 2015 JMP Securities Life Sciences Conference
2015-06-15,Argos Therapeutics Hires John D. Menditto As Vice President Of Corporate Communications And Investor Relations
2015-06-04,Independent Data Monitoring Committee Recommends Continuation Of Pivotal ADAPT Phase 3 Clinical Trial Of AGS-003 For Metastatic Renal Cell Carcinoma
2015-05-29,Argos Therapeutics To Present At The Annual Sachs Immuno-Oncology: BD&L And Investment Forum
2015-05-20,Argos Therapeutics To Present At The World Stem Cells Regenerative Medicine Congress 2015
2015-05-14,Argos Therapeutics Reports First Quarter 2015 Financial Results And Operational Highlights
2015-05-13,Argos Therapeutics Provides Update On Enrollment Progress For Ongoing Pivotal Phase 3 ADAPT Clinical Trial
2015-05-08,Argos Therapeutics To Present At 36th American Society For Apheresis Annual Meeting
2015-05-07,Argos Therapeutics To Hold First Quarter 2015 Financial Results Conference Call On Thursday, May 14, 2015
2015-04-23,Argos Therapeutics Recognized For Economic Development At The 17th Annual Triangle CREW Champion Awards
2015-04-21,Argos Therapeutics Announces Publication Of Data From Phase 2 Clinical Trial Of AGS-003 Fully Personalized Immunotherapy For Treatment Of Metastatic Renal Cell Carcinoma (mRCC)
2015-04-20,Argos Therapeutics To Present Update On Pivotal Phase 3 ADAPT Clinical Trial During 2015 ASCO Annual Meeting
2015-04-14,Argos Therapeutics Licenses Arcelis(R) Technology Platform To Lummy HK For Development Of Personalized Immunotherapies To Treat Cancer In China
2015-04-07,Argos Therapeutics To Present At The 14th Annual Needham Healthcare Conference
2015-04-02,Market News: CarMax, Motorola Solutions, Argos Therapeutics
2015-04-01,Ratings Changes Today
2015-04-01,NIH Funds Study Of Fully Personalized Immunotherapy AGS-004 Combined With A Latency Reversing Therapy For The Treatment Of HIV
2015-03-30,Argos Therapeutics Reports Fourth Quarter And Year-End 2014 Financial Results
2015-03-20,Argos Therapeutics Director Of Immunology To Present At HIV Vaccines Meeting
2015-03-16,Argos Therapeutics To Hold Fourth Quarter And Year-End 2014 Financial Results Conference Call On Monday, March 30, 2015
2015-03-04,Argos Therapeutics To Present At Three Upcoming Investor Conferences In March
2015-02-27,Argos Therapeutics Announces Update On Phase 3 ADAPT Trial To Be Presented During 2015 ASCO Genitourinary Cancers Symposium
2015-02-24,Joan C. Winterbottom Joins Argos Therapeutics As Chief Human Resources Officer
2015-02-02,Argos Therapeutics To Present At The 17th Annual BIO CEO & Investor Conference
2015-01-23,Argos Therapeutics Chief Operating Officer To Speak At Phacilitate Cell & Gene Therapy Forum 2015
2015-01-22,Argos Therapeutics Director Of Immunology To Speak At The GTCbio Novel Immunotherapeutics Summit 2015
2015-01-20,Argos Therapeutics Chief Scientific Officer To Speak At The Personalized Medicine World Conference 2015
2015-01-09,Oversold Conditions For Argos Therapeutics(ARGS)
2015-01-09,Argos Therapeutics Provides Update On Clinical Research For Investigational Fully Personalized Immunotherapy For The Treatment Of HIV
2015-01-06,Argos Therapeutics To Present At Biotech Showcase 2015
2015-01-06,Argos Therapeutics And Saint-Gobain Announce Agreement For Production Of Disposables Used In Automated Manufacturing Of Fully Personalized Immunotherapies
2014-11-25,Argos Therapeutics To Present At The 26th Annual Piper Jaffray Healthcare Conference
2014-11-24,Argos Therapeutics Receives 2014 Red Herring North America Top 100 Award
2014-11-13,Argos Therapeutics Reports Third Quarter 2014 Financial Results And Operational Highlights
2014-11-13,Philippe Van Holle Joins Argos Therapeutics Board Of Directors
2014-11-12,Argos Therapeutics To Present At The Stifel 2014 Healthcare Conference
2014-11-06,Argos Therapeutics To Hold Third Quarter 2014 Financial Results Conference Call On Thursday, November 13, 2014
2014-11-05,Invetech And Argos Therapeutics Announce Agreement To Support Global Production Of Fully Personalized Immunotherapies
2014-10-22,Argos Therapeutics Breaks Ground On State-of-the-Art Biomanufacturing Facility In Research Triangle Park Area
2014-10-03,Argos Therapeutics Announces Plans For New Manufacturing Facility In Research Triangle Park Area In Durham, North Carolina
2014-10-01,Argos Therapeutics To Present At The 13th Annual BIO Investor Forum
2014-09-30,Argos Therapeutics Enters Into $25 Million Venture Loan Facility Led By Horizon Technology Finance
2014-09-19,Argos Therapeutics To Present At The 21st Annual BioCentury NewsMakers Conference
2014-09-18,Enrollment In Argos Therapeutics' Pivotal Phase III ADAPT Trial Of AGS-003 For Metastatic Renal Cell Carcinoma Surpasses Fifty Percent
2014-09-08,Argos Announces Issuance Of Arcelis(R) Technology Platform Patent
2014-09-03,Argos Therapeutics To Present At The Rodman & Renshaw 16th Annual Global Investment Conference
2014-08-13,Argos Therapeutics Reports Second Quarter 2014 Financial Results And Operational Highlights
2014-08-06,Argos Therapeutics To Hold Second Quarter 2014 Financial Results Conference Call On Wednesday, August 13, 2014
2014-07-21,Argos Therapeutics Presents Data Showing The Impact Of HIV Antigen Sequence Divergence On Durable Viral Control Following Treatment With Autologous Immune Therapy
2014-06-11,Argos Therapeutics To Present At Two Upcoming Healthcare Conferences
2014-06-05,Argos Therapeutics To Host Post-American Society Of Clinical Oncology (ASCO) Conference Call And Webcast, Monday, June 9, 2014
2014-06-02,Treatment With AGS-003 And Sunitinib Associated With Doubling Of Expected Survival In Patients With Unfavorable Risk Metastatic Renal Cell Carcinoma (mRCC)
2014-05-28,Argos Therapeutics To Present At The Jefferies 2014 Global Healthcare Conference
2014-05-27,Argos Therapeutics Named As A Red Herring Top 100 North America Winner
2014-05-19,Argos Therapeutics CSO Dr. Charles Nicolette To Join Panel Discussion On Challenges In Clinical Trial Development At The Society Of Gene & Cell Therapy Annual Meeting
2014-05-15,Argos Therapeutics COO Fred Miesowicz To Join Panel Discussion On Manufacturing Challenges In Cell Therapy At The World Stem Cells And Regenerative Medicine Congress
2014-05-13,Argos Therapeutics Reports First Quarter 2014 Financial Results
2014-05-12,Argos Therapeutics To Present Data Related To Clinical Development Program For AGS-003 During 2014 ASCO Annual Meeting
2014-04-29,Argos Therapeutics To Hold First Quarter 2014 Financial Results Conference Call On Tuesday, May 13, 2014
2014-04-07,Argos Therapeutics Announces Filing Of Its Annual Report On Form 10-K
2014-04-01,Argos Therapeutics To Present At The 13th Annual Needham Healthcare Conference
2014-03-31,Argos Therapeutics Added To Russell 2000(R) And 3000(R) Indexes
2014-03-27,Argos Therapeutics Reports Fourth Quarter And Year-End 2013 Financial Results
2014-03-21,Argos Therapeutics To Present At 21st Annual Future Leaders In The Biotech Industry Conference
2014-03-19,Argos Therapeutics To Present At Regenerative Medicine And Cancer Immunotherapy Meetings
2014-03-17,Argos Therapeutics To Present At The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum
2014-03-14,Argos Therapeutics To Hold Fourth Quarter And Year End 2013 Financial Results Conference Call On Thursday, March 27, 2014
2014-03-04,Argos Therapeutics Presents New Data From Clinical Research For AGS-004 Patient-Specific Immunotherapy In Treatment Of HIV
2014-02-13,Top Insider Trades: EPB BYI ARGS BIOL
2014-02-07,Argos Therapeutics Prices Initial Public Offering
